Skip to main content
. 2017 Jun 13;15:137. doi: 10.1186/s12967-017-1237-1

Table 4.

Changes in CGI-S Scale during treatment

Group
“Pure ”PD (n = 42) “Comorbid” PD (n = 39) Total (n = 81)
n % n % n %
CGI-S, V1
 Moderately expressed disease 4 10.3 1 2.4 5 6.2
 Significantly expressed disease 34 87.2 38 90.5 72 88.9
 Serious disease 1 2.6 3 7.1 4 4.9
 Total 39 100.0 42 100.0 81 100.0
CGI-S, V2
 Moderately expressed disease 19 48.7 1 2.4 20 24.7
 Significantly expressed disease 20 51.3 39 92.9 59 72.8
 Serious disease 0 .0 2 4.8 2 2.5
 Total 39 100.0 42 100.0 81 100.0
CGI-S, V3
 Moderately expressed disease 19 48.7 5 11.9 24 29.6
 Significantly expressed disease 20 51.3 37 88.1 57 70.4
 Total 39 100.0 42 100.0 81 100.0
CGI-S, V4
 Weakly expressed disease 0 .0 20 47.6 20 24.7
 Moderately expressed disease 20 51.3 22 52.4 42 51.9
 Significantly expressed disease 19 48.7 0 .0 19 23.5
 Total 39 100.0 42 100.0 81 100.0
CGI-S, V5
 Borderline state 0 .0 6 14.3 6 7.4
 Weakly expressed disease 1 2.6 36 85.7 37 45.7
 Moderately expressed disease 37 94.9 0 .0 37 45.7
 Significantly expressed disease 1 2.6 0 .0 1 1.2
 Total 39 100.0 42 100.0 81 100.0
CGI-S, V6
 Normal state 0 .0 5 11.9 5 6.2
 Borderline state 32 82.1 37 88.1 69 85.2
 Weakly expressed disease 7 17.9 0 .0 7 8.6
 Total 39 100.0 42 100.0 81 100.0